NEW YORK, July 09, 2024 (GLOBE NEWSWIRE) — The Gross Law Firm issues the following notice to shareholders of Humana Inc. (NYSE: HUM).
Shareholders who purchased shares of HUM during the class period listed are encouraged to contact the firm regarding possible lead plaintiff appointment. Appointment as lead plaintiff is not required to partake in any recovery.
CONTACT US HERE:
CLASS PERIOD: July 27, 2022 to January 24, 2024
ALLEGATIONS: According to the filed complaint, defendants made false and/or misleading statements and/or failed to disclose that: Specifically, defendants downplayed pressures on the Company’s adjusted earnings per share resulting from increased medical costs associated with pent-up demand for healthcare procedures which, contrary to the Company’s assurances, resulted in increased utilization rates and costs.
DEADLINE: August 2, 2024 Shareholders should not delay in registering for this class action. Register your information here: https://securitiesclasslaw.com/securities/humana-loss-submission-form/?id=89667&from=3
NEXT STEPS FOR SHAREHOLDERS: Once you register as a shareholder who purchased shares of HUM during the timeframe listed above, you will be enrolled in a portfolio monitoring software to provide you with status updates throughout the lifecycle of the case. The deadline to seek to be a lead plaintiff is August 2, 2024. There is no cost or obligation to you to participate in this case.
WHY GROSS LAW FIRM? The Gross Law Firm is a nationally recognized class action law firm, and our mission is to protect the rights of all investors who have suffered as a result of deceit, fraud, and illegal business practices. The Gross Law Firm is committed to ensuring that companies adhere to responsible business practices and engage in good corporate citizenship. The firm seeks recovery on behalf of investors who incurred losses when false and/or misleading statements or the omission of material information by a company lead to artificial inflation of the company’s stock. Attorney advertising. Prior results do not guarantee similar outcomes.
CONTACT:
The Gross Law Firm
15 West 38th Street, 12th floor
New York, NY, 10018
Email: dg@securitiesclasslaw.com
Phone: (646) 453-8903
- Iterum Therapeutics Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4) - July 2, 2025
- WST DEADLINE: ROSEN, A LONGSTANDING FIRM, Encourages West Pharmaceutical Services, Inc. Investors with Losses in Excess of $100K to Secure Counsel Before Important July 7 Deadline in Securities Class Action – WST - July 2, 2025
- Cellectar Biosciences Announces Closing of $6.9 Million Underwritten Public Offering, including Full Exercise of Over-Allotment Option - July 2, 2025
